Dr Lal Path Labs reports consolidated Q2 FY26 PAT at Rs. 150.6 Cr
News

Dr Lal Path Labs reports consolidated Q2 FY26 PAT at Rs. 150.6 Cr

The company has posted net profit of Rs. 283 crore for the 6 months period ended September 30, 2025

  • By IPP Bureau | November 02, 2025

Dr. Lal Path Labs Ltd. has reported consolidated financial results for the period ended September 30, 2025.

Dr. Lal Path Labs has posted net profit of Rs. 150.6 crore for the period ended September 30, 2025 as against net profit of Rs. 132.4 crore for the period ended June 30, 2025. The company posted net profit of Rs. 129.2 crore for the period ended September 30, 2024.

Dr. Lal Path Labs has reported total income of Rs. 755.4 crore during the period ended September 30, 2025 as compared to Rs. 697.9 crore during the period ended June 30, 2025. The company reported total income of Rs. 682.1 crore during the period ended September 30, 2024.

For the Half Year ended September 30, 2025, Dr. Lal Path Labs has reported total income of Rs. 1,453.3 crore as compared to Rs. 1,304.6 crore during the 6 months period ended September 30, 2024.

The company has posted net profit of Rs. 283 crore for the 6 months period ended September 30, 2025 as against net profit of Rs. 235.6 crore for the 6 months period ended September 30, 2024.

Other Related stories

Startup

Digitization

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International